Biocytogen Pharmaceuticals (beijing) Co., Ltd.

Biocytogen Pharmaceuticals Co., Ltd.

Yuting Hu

Rui Huang

Yang Bai

Yuelei Shen

Yanan Guo

Xiaofei Zhou

Jichao Du

Provided is a method for preparing a PD-1 gene-modified humanized animal model. The method utilizes the CRIPSR/Cas9 technique to replace partial fragments of a mouse PD-1 gene with fragments of a human PD-1 gene using homologous recombination by constructing a targeting vector, thereby preparing a gene-modified humanized mouse. This mouse can normally express a PD-1 protein containing the functional domain of the human PD-1 protein, and can be used as an animal model for mechanism research regarding PD-1, PD-L1 and other signals, for screening regulators, and for toxicological research. The method has an important and high application value in studies on functions of the PD-1 gene and in the development of new drugs.

Method for constructing PD-1 gene modified humanized animal model and use thereof

Genetically modified mice expressing humanized PD-1

Growing community of inventors

Beijing, China

Yuting Hu